EVR vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

EVR

39.7
AI Score
VS
IVZ Wins

IVZ

63.5
AI Score

Investment Advisor Scores

EVR

40score
Recommendation
AVOID NEW MONEY

IVZ

64score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric EVR IVZ Winner
Forward P/E 14.1643 8.9767 IVZ
PEG Ratio 1.1895 0.9008 IVZ
Revenue Growth 12.4% 14.2% IVZ
Earnings Growth 15.2% -1.5% EVR
Tradestie Score 39.7/100 63.5/100 IVZ
Profit Margin 15.7% -1.1% EVR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY STRONG BUY IVZ

Relative Price Performance (Last 90 Days)

EVR 1M: +12.9% · 3M: -4.6% IVZ 1M: -1.0% · 3M: -11.5%

Current Technical Phase

EVR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.3 · Price: $298.08

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $28.63

Fundamentals Snapshot

Metric EVR IVZ
Market Cap — —
Forward P/E 13.9 8.7
Trailing P/E 16.1 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.9% 0.3%
Operating Margin 0.2% 0.2%
EPS 18.28 -0.69
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.